ENZO BIOCHEM, INC. Lease, Cost
ENZO BIOCHEM, INC. reported Lease, Cost of $957.00 thousand for the 3-month period ending 2023-04-30, per its 10-Q filed 2023-06-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2023-06-14
- ENZO BIOCHEM, INC. lease, cost for the quarter ending 2023-04-30 was $957.00K, a 13.55% decline year-over-year.
- ENZO BIOCHEM, INC. lease, cost for the quarter ending 2023-01-31 was $932.00K, a 18.96% decline year-over-year.
- ENZO BIOCHEM, INC. lease, cost for the quarter ending 2022-10-31 was $1.07M, a 9.41% decline year-over-year.
- ENZO BIOCHEM, INC. lease, cost for the quarter ending 2022-07-31 was $1.08M, a 12.34% decline year-over-year.
- ENZO BIOCHEM, INC. lease, cost for fiscal 2022 was $4.52M, a 19.73% decline from fiscal 2021.
- ENZO BIOCHEM, INC. lease, cost for fiscal 2021 was $5.63M, a 7.74% decline from fiscal 2020.
- ENZO BIOCHEM, INC. lease, cost for fiscal 2020 was $6.10M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-04-30 | $957.00K 10-Q · filed 2023-06-14 | $1.89M derived: sum of 2 quarters · filed 2023-06-14 | $2.96M 10-Q · filed 2023-06-14 | $4.04M derived: sum of 4 quarters · filed 2023-06-14 |
| 2023-01-31 | $932.00K 10-Q · filed 2023-03-20 | $2.00M 10-Q · filed 2023-03-20 | $3.08M derived: sum of 3 quarters · filed 2023-03-20 | $4.19M derived: sum of 4 quarters · filed 2023-06-14 |
| 2022-10-31 | $1.07M 10-Q · filed 2022-12-12 | $2.15M derived: sum of 2 quarters · filed 2022-12-12 | $3.26M derived: sum of 3 quarters · filed 2023-06-14 | $4.41M derived: sum of 4 quarters · filed 2023-06-14 |
| 2022-07-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-14 | $2.19M derived: sum of 2 quarters · filed 2023-06-14 | $3.34M derived: sum of 3 quarters · filed 2023-06-14 | $4.52M 10-K · filed 2022-10-14 |
| 2022-04-30 | $1.11M 10-Q · filed 2023-06-14 | $2.26M derived: sum of 2 quarters · filed 2023-06-14 | $3.44M 10-Q · filed 2023-06-14 | $4.67M derived: sum of 4 quarters · filed 2023-06-14 |
| 2022-01-31 | $1.15M 10-Q · filed 2023-03-20 | $2.33M 10-Q · filed 2023-03-20 | $3.56M derived: sum of 3 quarters · filed 2023-03-20 | $4.86M derived: sum of 4 quarters · filed 2023-03-20 |
| 2021-10-31 | $1.18M 10-Q · filed 2022-12-12 | $2.41M derived: sum of 2 quarters · filed 2022-12-12 | $3.71M derived: sum of 3 quarters · filed 2022-12-12 | $5.26M derived: sum of 4 quarters · filed 2022-12-12 |
| 2021-07-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-14 | $2.52M derived: sum of 2 quarters · filed 2022-10-14 | $4.08M derived: sum of 3 quarters · filed 2022-10-14 | $5.63M 10-K · filed 2022-10-14 |
| 2021-04-30 | $1.29M 10-Q · filed 2022-06-09 | $2.85M derived: sum of 2 quarters · filed 2022-06-09 | $4.39M 10-Q · filed 2022-06-09 | $5.87M derived: sum of 4 quarters · filed 2022-06-09 |
| 2021-01-31 | $1.55M 10-Q · filed 2022-03-14 | $3.10M 10-Q · filed 2022-03-14 | $4.58M derived: sum of 3 quarters · filed 2022-03-14 | $6.12M derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-10-31 | $1.55M 10-Q · filed 2021-12-15 | $3.03M derived: sum of 2 quarters · filed 2021-12-15 | $4.56M derived: sum of 3 quarters · filed 2021-12-15 | $6.12M derived: sum of 4 quarters · filed 2021-12-15 |
| 2020-07-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | $3.01M derived: sum of 2 quarters · filed 2021-10-12 | $4.57M derived: sum of 3 quarters · filed 2021-10-12 | $6.10M 10-K · filed 2021-10-12 |
| 2020-04-30 | $1.53M 10-Q · filed 2021-06-11 | $3.09M derived: sum of 2 quarters · filed 2021-06-11 | $4.62M 10-Q · filed 2021-06-11 | |
| 2020-01-31 | $1.56M 10-Q · filed 2021-03-16 | $3.10M 10-Q · filed 2021-03-16 | ||
| 2019-10-31 | $1.54M 10-Q · filed 2019-12-10 |